Budesonide with multi-matrix technology as second-line treatment for ulcerative colitis: evaluation of long-term cost-effectiveness in the Netherlands
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2018 |
Reihe/Periodikum: | Journal of Medical Economics ; volume 21, issue 9, page 869-877 ; ISSN 1369-6998 1941-837X |
Verlag/Hrsg.: |
Informa UK Limited
|
Schlagwörter: | Health Policy |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26819080 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://dx.doi.org/10.1080/13696998.2018.1484371 |